In the latest session, Option Care Health Inc. (NASDAQ: OPCH) closed at $31.80 down -1.88% from its previous closing price of $32.41. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 1221304 shares were traded. OPCH stock price reached its highest trading level at $32.46 during the session, while it also had its lowest trading level at $31.45.
Ratios:
For a deeper understanding of Option Care Health Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.80.
On July 19, 2021, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $20 to $25.
On January 22, 2021, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $22.Deutsche Bank initiated its Buy rating on January 22, 2021, with a $22 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 28 ’24 when Bavaro Michael sold 1,984 shares for $31.73 per share. The transaction valued at 62,944 led to the insider holds 43,428 shares of the business.
KRAEMER HARRY M JANSEN JR bought 35,000 shares of OPCH for $1,104,352 on Feb 26 ’24. The Director now owns 269,528 shares after completing the transaction at $31.55 per share. On Oct 30 ’23, another insider, Bierbower Elizabeth D, who serves as the Director of the company, bought 3,000 shares for $26.37 each. As a result, the insider paid 79,110 and bolstered with 13,515 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPCH now has a Market Capitalization of 5.51B and an Enterprise Value of 6.33B. As of this moment, Option’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.50, and their Forward P/E ratio for the next fiscal year is 24.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.28 while its Price-to-Book (P/B) ratio in mrq is 3.90. Its current Enterprise Value per Revenue stands at 1.47 whereas that against EBITDA is 13.42.
Stock Price History:
Over the past 52 weeks, OPCH has reached a high of $35.74, while it has fallen to a 52-week low of $24.23. The 50-Day Moving Average of the stock is 32.31, while the 200-Day Moving Average is calculated to be 32.04.
Shares Statistics:
For the past three months, OPCH has traded an average of 1.34M shares per day and 974.72k over the past ten days. A total of 174.58M shares are outstanding, with a floating share count of 171.62M. Insiders hold about 1.08% of the company’s shares, while institutions hold 98.84% stake in the company. Shares short for OPCH as of Feb 29, 2024 were 4.27M with a Short Ratio of 3.20, compared to 3.78M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.46% and a Short% of Float of 2.79%.
Earnings Estimates
There are 8 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.23 for the current quarter, with a high estimate of $0.25 and a low estimate of $0.19, while EPS last year was $0.21. The consensus estimate for the next quarter is $0.28, with high estimates of $0.29 and low estimates of $0.27.
Analysts are recommending an EPS of between $1.18 and $1.08 for the fiscal current year, implying an average EPS of $1.13. EPS for the following year is $1.31, with 8 analysts recommending between $1.43 and $1.23.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $1.1B this quarter.It ranges from a high estimate of $1.11B to a low estimate of $1.09B. As of the current estimate, Option Care Health Inc.’s year-ago sales were $1.02B, an estimated increase of 8.50% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $1.17B, an increase of 9.00% over than the figure of $8.50% in the same quarter last year. There is a high estimate of $1.18B for the next quarter, whereas the lowest estimate is $1.15B.
A total of 8 analysts have provided revenue estimates for OPCH’s current fiscal year. The highest revenue estimate was $4.75B, while the lowest revenue estimate was $4.69B, resulting in an average revenue estimate of $4.71B. In the same quarter a year ago, actual revenue was $4.3B, up 9.40% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $5.12B in the next fiscal year. The high estimate is $5.18B and the low estimate is $5.05B. The average revenue growth estimate for next year is up 8.90% from the average revenue estimate for this year.
